Showing results (251-260 of 1,674) with videos related to
Sort By:
Pageof 168
British Journal of Clinical Pharmacology|November 6, 1998
Compliance with restrictions on the subsidized use of proton pump inhibitors in AustraliaP McManus, J Marley, D J Birkett, et al.Trends in Parasitology|October 27, 2012
Role of resident liver cells in the pathogenesis of schistosomiasisBarrie J Anthony, Grant A Ramm, Donald P McManusParasite Immunology|March 10, 2001
Vaccine efficacy of recombinant cathepsin D aspartic protease from Schistosoma japonicumC K Verity, D P McManus, P J BrindleyPharmacoepidemiology and Drug Safety|January 5, 2002
Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in AustraliaP McManus, D J Birkett, J Dudley, et al.Parasitology|February 8, 2012
Serine protease inhibitors of parasitic helminthsAdebayo J Molehin, Geoffrey N Gobert, Donald P McManusInternational Journal for Parasitology|January 5, 2000
Developmental expression of cathepsin D aspartic protease in Schistosoma japonicumC K Verity, D P McManus, P J BrindleyParasite Immunology|June 1, 1995
Further characterization of the 38 kDa antigen from Echinococcus granulosus (hydatid disease) cyst fluid: evidence for antigenic heterogeneity and reactivity with anti-P1 antibodiesL H Zhang, G R Leggatt, D P McManusThe Medical Journal of Australia|January 6, 1992
A genetic comparison of human and wildlife isolates of Echinococcus granulosus in Queensland: public health implicationsM Hope, J Bowles, P Prociv, et al.Frontiers in Immunology|March 11, 2021
Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological DisordersYi Mu, Donald P McManus, Nan Hou, et al.Tropical Medicine and Infectious Disease|October 3, 2018
DNA Diagnostics for Schistosomiasis ControlKosala G Weerakoon, Catherine A Gordon, Donald P McManusPageof 168